KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other Non-Current Liabilities (2017 - 2026)

Moderna (MRNA) has disclosed Other Non-Current Liabilities for 10 consecutive years, with $283.0 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities rose 3.28% year-over-year to $283.0 million; the TTM value through Mar 2026 reached $283.0 million, up 3.28%, while the annual FY2025 figure was $285.0 million, 6.74% up from the prior year.
  • Other Non-Current Liabilities hit $283.0 million in Q1 2026 for Moderna, down from $285.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $285.0 million in Q4 2025 and bottomed at $81.0 million in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $214.9 million, with a median of $262.0 million recorded in 2024.
  • Year-over-year, Other Non-Current Liabilities soared 11200.0% in 2022 and then increased 1.81% in 2025.
  • Moderna's Other Non-Current Liabilities stood at $135.0 million in 2022, then skyrocketed by 89.63% to $256.0 million in 2023, then rose by 4.3% to $267.0 million in 2024, then increased by 6.74% to $285.0 million in 2025, then decreased by 0.7% to $283.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $283.0 million, $285.0 million, and $281.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.